Moderna, Inc. (MRNA) Q3 2021 Earnings Results

Moderna Misses on EPS, Stock Down 17.89%

This earnings report indicates that Moderna's performance fell short of expectations, particularly in EPS. The stock reacted negatively, dropping nearly 18%, likely due to investor concerns over the company's ability to meet future earnings targets and the lack of guidance. The management's defensive tone suggests they are aware of the challenges ahead.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$7.70	N/A	-14.01%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Defensive

Management expressed concerns about the current market environment. They highlighted the need for strategic adjustments moving forward.

Management acknowledged challenges in meeting market expectations.

They emphasized ongoing efforts to enhance production capabilities.

Moderna Misses on EPS, Stock Down 17.89%

Key numbers

Management commentary

Moderna, Inc.

More earnings this week

Moderna Misses on EPS, Stock Down 17.89%

Key numbers

Management commentary